🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It was an absolute honour having Camille Lobry visiting our lab today. He gave an amazing presentation about super-enhancers in AML. Amazing work Camille! It was wonderfull having you here #leukemiaresearch #leukemia

Congratulations Dr. De Coninck! 🧑‍🎓 Well done on this fantastic achievement. It has been a privilege to support your research. Good luck with your next adventure. A big thank you to jury members Camille Lobry Marlies Vanden Bempt Igor Fijałkowski and Dr. Maaike Van Trimpont 🤓

Very happy and proud to have been part of the PhD committee of the awesome Stien de Coninck ! Congrats on the great work ! Enjoyed wearing the gown with Steven Goossens

Qui n'a pas passé des heures à la bibliothèques à potasser la Biochimie de Lubert Stryer ?

1/ Excited to share our study with Kris Wood and @MartinCNRS on AML's dependency on PI3Kg, aligned with findings from Andy Lane and Zhao labs. It links to Venetoclax sensitivity and shows the promise of degradation over inhibition to enhance cytotoxicity. rdcu.be/dJq10

2 / We warmly thank our collaborators from Krogan Lab, Benajiba Lina, Camille Lobry labs, Institut Curie, and the clinical team from Hôpital Saint-Louis AP-HP for their critical help, as well as the thoughtful comments from our reviewers. rdcu.be/dJq10 nature.com/articles/s4301…

3 / A summary of this study is available here: go.nature.com/4525zEg

Our Holiday present is here, an exciting deep dive on 3D nuclear and chromosomal landscapes in acute leukemia, out today Molecular Cell ! A multi-year effort to define and study 3D chromosomal hubs spearheaded by Giovanni Gambi and Francesco Boccalatte in (very) close collaboration with

👏 Alexandre Puissant a remporté le prestigieux Prix Galien France 2024 ! Alexandre Puissant dirige une équipe de recherche à l'Institut de la Leucémie Paris Saint-Louis Alex Puissant Lab 🔬 Ses travaux portent principalement sur la compréhension des mécanismes de progression et de

Our study on T-ALL heterogeneity is out! We show ~1/3 of T-ALLs express inflammatory/stem signatures and are sensitive to venetoclax. Huge congrats to @gowerfulScience for leading the way, Soheil Jahangiri, and the entire team! science.org/doi/10.1126/sc…

I feel like we could all use something fun to look forward to right about now 👇 Abstract submission and registration are open for the FASEB Hematologic Malignancies meeting. This is always the BEST meeting!!! Please RT! events.faseb.org/event/hematolo…

Last call for our amazing Fusion Conferences focusing on Myeloid Malignancies taking place this May in beautiful Crete, Greece! Few registration slots remaining! fusion-conferences.com/conference/180

Wonderful time with Paolo Gallipoli visiting us at Institut de Recherche Saint-Louis (IRSL) to give an inspiring seminar on the role of fatty acid metabolism in leukemia. Thank you so much Paolo and see you soon

Excited to share our paper out today in Cell Press discovering RNA mis-splicing derived neoantigens & their cognate T cell receptors (TCRs) as well as characterization of endogenous neoantigen T cells in leukemia patients. authors.elsevier.com/sd/article/S00…